Market Research Insights

San Francisco, 3 July 2019:   The Report   Diabetes Devices Market   Analysis By Device Type (Self-monitoring & Diagnostic Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor & Test Strips)), Delivery Type (Syringes, Pumps, Pens, Injectors) And Segment Forecasts To 2024 The global diabetes devices market size was valued at USD 20.7 billion in 2016 and is expected to develop at a CAGR of 7.0% over the forecast period. Demand for diabetes devices is increasing due to growth in target population base. Growing cases of diabetes caused due to obesity, unhealthy lifestyles and eating habits, age, and other factors are leading factors driving market growth. Obesity is believed to be one of the foremost factors leading to the development of diabetes in individuals. Some of the key companies in the global diabetes devices market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roc

San Francisco, 18 March 2019:  The Report  Diabetes Devices Market  Analysis By Device Type (Self-monitoring & Diagnostic Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor & Test Strips)), Delivery Type (Syringes, Pumps, Pens, Injectors) And Segment Forecasts To 2024 The global Diabetes Devices Market size is expected to reach USD 35.5 billion by 2024, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.0% during the forecast period. Growing cases of diabetes, due to obesity, sedentary and unhealthy lifestyles, and several other factors, is expected to drive demand for diabetes devices over the next few years. Obesity is believed to be one of the foremost factors leading to diabetes in individuals. According to WHO, in 2014, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese. Some of the key companies in the global diabetes devices market are Medtron